Two of Pfizer’s former top executives have pitched at least four of its directors, including chief executive Albert Bourla, on activist investor Starboard Value’s plan for turning around the ...
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...